CAR-T therapy and targeted treatments: Emerging combination strategies in solid tumors

Area of Science:

• Immunotherapy
• Oncology
• Cellular Therapy

Background:

• Chimeric antigen receptor T-cell (CAR-T) therapy offers potential for long-term remission in malignancies.
• Solid tumors present significant challenges for CAR-T efficacy, including limited infiltration, poor cancer recognition, reduced cytotoxicity, exhaustion, and toxicity.

Purpose of the Study:

• To review current combined strategies of CAR-T therapies and targeted therapies for solid tumors.
• To outline potential mechanisms of action for these combined approaches.
• To provide insights for future research directions in this field.

Main Methods:

• Systematic review of existing experimental and clinical evidence.
• Analysis of combined CAR-T cell therapy and targeted inhibitor strategies.

Main Results:

• Combination therapy enhances CAR-T cell infiltration into tumor sites.
• Synergistic approaches improve cancer recognition, cytotoxicity, and memory phenotype development.
• Integrated strategies show potential in alleviating CAR-T cell exhaustion and reducing toxicity.

Conclusions:

• Combining CAR-T therapies with targeted inhibitors is a promising strategy to overcome challenges in solid tumor treatment.
• This approach may expand the therapeutic potential of CAR-T cells to a broader patient population with solid tumors.
• Further research is warranted to optimize these combined strategies for maximum clinical benefit.